Journal for ImmunoTherapy of Cancer (Nov 2023)
1181 GEN1042-mIgG2a, an Fc-inert mouse-human chimeric variant of GEN1042 (DuoBody®-CD40x4–1BB), exhibits in vivo antitumor activity and peripheral immune modulation
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)